Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Carparts.Com Inc (PRTS) Price & Performance

Inovio Pharmaceuticals IncTrade
Carparts.Com IncTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Carparts.Com Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.76 (market cap $78.55M), while Carparts.Com Inc trades at $6.34 (market cap $51.67M). The key difference: Inovio Pharmaceuticals Inc is the larger of the two by market cap, and Carparts.Com Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

INOPRTS
Market Cap
$78.55M$51.67M
Sector
HealthConsumer Cyclical
52-Week High
$2.87$11.40
52-Week Low
$0.66$3.88
Enterprise Value
$49.56M$66.64M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Inovio Pharmaceuticals Inc

INO trades at $0.76, up 2.74% today, but remains in a bearish technical trend. The company shows minimal revenue of $65K against high operating losses, with a net income margin of -130,000%. Recent quarterly EPS has beaten expectations. Analyst consensus is bullish with a $3.25 price target, but the stock faces significant fundamental challenges including negative cash flow and high valuation multiples.

The outlook hinges on FDA approval of INO-3107 in October 2026, a binary event that could drive substantial upside. However, persistent cash burn, negative profitability, and ongoing shareholder litigation present high risks. Investors should weigh the potential catalyst against the company's weak financial health and operational execution challenges.

Carparts.Com Inc

CarParts.com (PRTS) trades at $6.32, down 6.37% today, with a bullish technical signal despite negative profitability metrics. The company has beaten earnings expectations for three consecutive quarters, though revenue has declined from $676M in 2023 to $548M in 2025. Recent developments include a 10:1 reverse stock split completed in May 2026 and a new $25M credit facility, while analyst consensus remains positive with 60% buy ratings.

The outlook is mixed: technical indicators and analyst sentiment suggest potential upside, but fundamental challenges persist with negative net income margins and cash flow concerns. Key risks include ongoing operational losses and competitive pressures in the auto parts e-commerce space, requiring careful monitoring of the company's turnaround execution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS